SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-003400
Filing Date
2022-06-22
Accepted
2022-06-22 16:32:59
Documents
1
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4053
  Complete submission text file 0001179110-22-003400.txt   5682
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TEMPEST THERAPEUTICS, INC. 7000 SHORELINE COURT, SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address
Whiting Samuel (Reporting) CIK: 0001870373 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 221032449